Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
Greece eyes migrant repatriation centres outside the EU- What's the new 'Knives Out' mystery about? Everything to know about 'Wake Up Dead Man,' including who's in the cast and what the reviews say.
- Audits of Espresso Types: Which Mix Is for You?
- Is Trump going to war with Venezuela?
- Full SNAP benefits must be paid ‘promptly,’ USDA tells states as government reopens
- Well known SUVs With Low Energy Utilization In 2024 vote
- Investigate Something else for Less: Financial plan Travel Objections
- Instructions to Pick the Right Senior Protection Plan.
- Bronze Age "City of Seven Ravines" unearthed in central Asia after 3,500 years
